Akebia Therapeutics Inc. (NASDAQ:AKBA) is one of the cheap penny stocks to invest in. On December 1, Akebia Therapeutics announced the official establishment of its rare kidney disease pipeline. This ...
AKB-9090 is being evaluated as a potential treatment for cardiac surgery-associated acute kidney injuryCAMBRIDGE, Mass., April 13, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a ...
Akebia Announces Positive Top-Line Results from its Phase 2b Study of AKB-6548 in Non-Dialysis Patients with Anemia Related to Chronic Kidney Disease Akebia Therapeutics, Inc. (NASDAQ:AKBA), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results